Aridis Pharmaceuticals names new chief medical officer
16 June 2020 -

Aridis Pharmaceuticals Inc (Nasdaq: ARDS), a US-based biopharmaceutical company, has named Dr Hasan Jafri as its new chief medical officer, it was reported on Monday.

Dr Jafri succeeds Dr Paul Mendelman who has been serving as the firm's interim CMO since October, 2019 and will transition to the role of senior medical advisor to the company.

Prior to joining Aridis Pharmaceuticals Inc, Dr Jafri worked at AstraZeneca, with the most recent position being held as the senior medical director, Clinical Research and Development, Microbial Sciences, clinical head of Antibacterial mAb Program, and coordinator of the COMBACTE-NET & COMBACTE-MAGNET consortia. He has more than 25 years of experience in clinical practice and research.